Penn Medicine spinout, cofounded by Carl June, developing an in vivo CAR-T immunotherapy platform ("Flare") intended as a universal treatment for solid tumors; ~75% of its ~60 employees are based in Philadelphia.
dispatchbio.comPart of: Philly Tech Startup Scene